SCHEMBL29635923

SCHEMBL29635923

CCC(O)CC(=O)[O-].CCC(O)CC(=O)[O-].[Mg+2]

nearest known ligand 0.56

Known targets — ChEMBL curated mechanism

ATP4AATP4BGABBR1GABBR2HMGCR

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC22A16 Q86VW1 1/20 0.56
CA4 P22748 2/20 0.46
CA2 P00918 2/20 0.46
CPT2 P23786 1/20 0.41
CPT1A P50416 1/20 0.41
FFAR3 O14843 2/20 0.38
HDAC3 O15379 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
NFKB1 P19838 1/20 0.38
CTSL P07711 1/20 0.37
GPR84 Q9NQS5 1/20 0.36
CASP1 P29466 1/20 0.35
MEN1 O00255 1/20 0.34
CYP2C19 P33261 1/20 0.34
RECQL P46063 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29635926 0.95 SLC22A16 (0.56) SLC22A16CA4CA2CPT2CPT1A
SCHEMBL21546042 0.95
Zinc Ion SCHEMBL28972722 0.95 SLC22A16 (0.56) SLC22A16CA4CA2CPT2CPT1A
SCHEMBL31500043 0.95
Potassium Ion SCHEMBL30197149 0.95
SCHEMBL28701377 0.95 SLC22A16 (0.56) SLC22A16CA4CA2CPT2CPT1A
SCHEMBL31500045 0.86 SLC22A6 (0.50) SLC22A16CA4CA2NFKB1GPR84
SCHEMBL10423091 0.77 CA4 (0.60) SLC22A16CA4CA2CPT2CPT1A
Silver SCHEMBL6733932 0.77 SLC22A16 (0.59) SLC22A16CA4CA2CPT2CPT1A
SCHEMBL6733940 0.77 SLC22A16 (0.59) SLC22A16CA4CA2CPT2CPT1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119968132-A Acid and salt compound and preparation method thereof 南京纽邦生物科技有限公司 2025-05-09 CN claimed
WO-2024067626-A1 COMPOSITE OF ACID AND SALT, AND PREPARATION METHOD THEREFOR 南京纽邦生物科技有限公司 2024-04-04 WO claimed
CN-119968132-A Acid and salt compound and preparation method thereof 南京纽邦生物科技有限公司 2025-05-09 CN disclosed
US-12167993-B2 Non-vasoconstricting energy-promoting compositions containing ketone bodies AXCESS GLOBAL SCIENCES, LLC (US) 2024-12-17 US disclosed
WO-2024067626-A1 COMPOSITE OF ACID AND SALT, AND PREPARATION METHOD THEREFOR 南京纽邦生物科技有限公司 2024-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12167993-B2 Non-vasoconstricting energy-promoting compositions containing ketone bodies GPR119, CPT1B, CYP11B1 SLC22A16 705/4885CA4 1702/4885CA2 893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.